5-FLUOROURACIL EBEWE
50MG/ML INJ SOL 1X20ML I
Announcement of launch, break or close-out of marketing of a medicinal product
| Type of announcement | Effective date | Alternate medicines ? | Reason for interruption/cessation of marketing | Estimated renewal date |
|---|---|---|---|---|
| Resumption of marketing | 25.05.2022 | |||
| Interruption of marketing | 31.03.2022 |
0012665, 0242251, 0242252 Dle indikací |
Capacity/distribution reasons | 20. týden |
| Resumption of marketing | 21.11.2019 | |||
| Interruption of marketing | 06.11.2019 |
0012665, 0126912, 0126913, 0242251 Dle indikací |
Capacity/distribution reasons | 49. týden |
| Resumption of marketing | 01.03.2017 | |||
| Interruption of marketing | 20.02.2017 |
0012665 |
||
| Resumption of marketing | 01.07.2013 | |||
| Interruption of marketing | 25.06.2012 | Lék ve specifickém léčebném programu | ||
| Resumption of marketing | 23.05.2012 | |||
| Interruption of marketing | 20.02.2012 | schválen specifický léčebný program | ||
| Resumption of marketing | 19.12.2011 | |||
| Resumption of marketing | 09.12.2011 | |||
| Interruption of marketing | 01.09.2011 |
0162382, 0162384, 0162386, 0162387 |
||
| Resumption of marketing | 01.08.2011 | |||
| Interruption of marketing | 22.06.2011 |
0012665, 0162382, 0162384, 0162386, 0162387, 0056055 |
All reports are available in the Overview.
cz